Lee H. Pai-Scherf
Internal Medicine
10903 New Hampshire Ave Rm 2314
Silver Spring, MD 20903
Silver Spring, MD 20903
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Keeping the End in Mind: Reviewing U.S. FDA Inspections of Submissions including Real-World Data.
Journal: Therapeutic innovation & regulatory science
Published: March 05, 2025
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 26, 2021
US Food and Drug Administration regulatory updates in neuro-oncology.
Journal: Journal of neuro-oncology
Published: May 10, 2021
FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With RET Gene Mutations or Fusions.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 17, 2021
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.
Journal: The oncologist
Published: January 29, 2021
Expansion Cohorts in First-in-Human Solid Tumor Oncology Trials.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 17, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026